{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:24:32Z","timestamp":1781112272660,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sepsis and septic shock are life-threatening conditions and remain an important medical problem, emphasizing the need to identify novel therapeutic approaches. Coagulation dysfunction, hypotension, disturbed microcirculation and multiorgan failure occur frequently. These severe conditions result from an overwhelming inflammatory response, induced by pathogen and damage associated molecular patterns (PAMPs and DAMPs) released into the bloodstream. In the present study, we demonstrated that the synthetic Lipopolysaccharid (LPS)-binding peptide 19-2.5 interferes with the activation of the coagulation and contact system. Moreover, binding of LPS to high molecular weight kininogen (HK), one of the major LPS carrier in blood, could be prevented by the peptide. Thus, peptide 19-2.5 might represent a promising target in the treatment of endotoxemia and sepsis, not only by its anti-inflammatory potential, but also by the anticoagulant effect, together with its ability to prevent degradation of HK.<\/jats:p>","DOI":"10.1038\/s41598-020-64155-5","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T10:04:21Z","timestamp":1588068261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The synthetic LPS binding peptide 19-2.5 interferes with clotting and prevents degradation of high molecular weight kininogen in plasma"],"prefix":"10.1038","volume":"10","author":[{"given":"Juliane","family":"K\u00f6hler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kreikemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Bajorath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sch\u00fcrholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Oehmcke-Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"64155_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0034-1398376","volume":"41","author":"M Levi","year":"2015","unstructured":"Levi, M. & Poll, T. V. D. Coagulation in patients with severe sepsis. Semin. Thromb. Hemost. 41, 9\u201315 (2015).","journal-title":"Semin. Thromb. Hemost."},{"key":"64155_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/infdis\/167.6.1336","volume":"167","author":"ME Evans","year":"1993","unstructured":"Evans, M. E. & Pollack, M. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J. Infect. Dis. 167, 1336\u20131343 (1993).","journal-title":"J. Infect. Dis."},{"key":"64155_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijmm.2007.03.006","volume":"297","author":"SM Opal","year":"2007","unstructured":"Opal, S. M. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int. J. Med. Microbiol. 297, 365\u2013377 (2007).","journal-title":"Int. J. Med. Microbiol."},{"key":"64155_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.arcmed.2004.07.006","volume":"35","author":"LN L\u00f3pez-Boj\u00f3rquez","year":"2004","unstructured":"L\u00f3pez-Boj\u00f3rquez, L. N., Dehesa, A. Z. & Reyes-Ter\u00e1n, G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Med. Res. 35, 465\u2013479 (2004).","journal-title":"Arch. Med. Res."},{"key":"64155_CR5","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1084\/jem.20161900","volume":"214","author":"A Yang","year":"2017","unstructured":"Yang, A. et al. An essential role of high-molecular-weight kininogen in endotoxemia. J. Exp. Med. 214, 2649\u20132670 (2017).","journal-title":"J. Exp. Med."},{"key":"64155_CR6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1172\/JCI108898","volume":"60","author":"RE Thompson","year":"1977","unstructured":"Thompson, R. E., Mandle, R. & Kaplan, A. P. Association of Factor-Xi and High Molecular-Weight Kininogen in Human-Plasma. J. Clin. Invest. 60, 1376\u20131380 (1977).","journal-title":"J. Clin. Invest."},{"key":"64155_CR7","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1073\/pnas.73.11.4179","volume":"73","author":"RJ Mandle","year":"1976","unstructured":"Mandle, R. J., Colman, R. W. & Kaplan, A. P. Identification of Prekallikrein and High-Molecular-Weight Kininogen as a Complex in Human-Plasma. Proc. Natl Acad. Sci. USA 73, 4179\u20134183 (1976).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64155_CR8","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3181\/00379727-139-36302","volume":"139","author":"HR Kimball","year":"1972","unstructured":"Kimball, H. R., Melmon, K. L. & Wolff, S. M. Endotoxin-Induced Kinin Production in Man. Proc. Soc. Exp. Biol. Med. 139, 1078\u20131082 (1972).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"64155_CR9","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.thromres.2014.03.018","volume":"133","author":"AH Schmaier","year":"2014","unstructured":"Schmaier, A. H. Physiologic activities of the Contact Activation System. Thromb. Res. 133, S41\u2013S44 (2014).","journal-title":"Thromb. Res."},{"key":"64155_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fimmu.2018.00312","volume":"9","author":"S Oehmcke-Hecht","year":"2018","unstructured":"Oehmcke-Hecht, S. & K\u00f6hler, J. Interaction of the Human Contact System with Pathogens-An Update. Front. Immunol. 9, 312 (2018).","journal-title":"Front. Immunol."},{"key":"64155_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1172\/JCI116201","volume":"91","author":"RA Pixley","year":"1993","unstructured":"Pixley, R. A. et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J. Clin. Invest. 91, 61\u201368 (1993).","journal-title":"J. Clin. Invest."},{"key":"64155_CR12","doi-asserted-by":"publisher","unstructured":"Gallimore, M. J. et al. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs. Elsevier https:\/\/doi.org\/10.1016\/0049-3848(78)90301-8 (1978).","DOI":"10.1016\/0049-3848(78)90301-8"},{"key":"64155_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1152\/ajpgi.1991.260.2.G213","volume":"260","author":"R Cadena DeLa","year":"1991","unstructured":"Cadena DeLa, R. et al. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am. J. Physiol.- Gastrointest. Liver Physiology 260, 213\u2013219 (1991).","journal-title":"Am. J. Physiol.- Gastrointest. Liver Physiology"},{"key":"64155_CR14","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1128\/AAC.00534-10","volume":"54","author":"T Gutsmann","year":"2010","unstructured":"Gutsmann, T. et al. New antiseptic peptides to protect against endotoxin-mediated shock. Antimicrob. Agents Chemother. 54, 3817\u20133824 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64155_CR15","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.bpj.2011.04.041","volume":"100","author":"Y Kaconis","year":"2011","unstructured":"Kaconis, Y. et al. Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophysical J. 100, 2652\u20132661 (2011).","journal-title":"Biophysical J."},{"key":"64155_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1182\/blood-2008-10-182527","volume":"114","author":"S Oehmcke","year":"2009","unstructured":"Oehmcke, S. et al. Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood 114, 444\u2013451 (2009).","journal-title":"Blood"},{"key":"64155_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1055\/s-0037-1613897","volume":"83","author":"T Mauron","year":"2000","unstructured":"Mauron, T., L\u00e4mmle, B. & Wuillemin, W. A. High molecular weight kininogen is cleaved by FXIa at three sites: Arg409-Arg410, Lys502-Thr503 and Lys325-Lys326. Thromb. Haemost. 83, 709\u2013714 (2000).","journal-title":"Thromb. Haemost."},{"key":"64155_CR18","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1099\/mic.0.2006\/003285-0","volume":"153","author":"LI P\u00e5hlman","year":"2007","unstructured":"P\u00e5hlman, L. I., Malmstr\u00f6m, E., M\u00f6rgelin, M. & Herwald, H. M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 153, 2458\u20132464 (2007).","journal-title":"Microbiology"},{"key":"64155_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1462-5822.2011.01705.x","volume":"14","author":"S Oehmcke","year":"2012","unstructured":"Oehmcke, S. et al. Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cell. Microbiol 14, 107\u2013119 (2012).","journal-title":"Cell. Microbiol"},{"key":"64155_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","volume":"118","author":"A Matafonov","year":"2011","unstructured":"Matafonov, A. et al. Activation of factor XI by products of prothrombin activation. Blood 118, 437\u2013445 (2011).","journal-title":"Blood"},{"key":"64155_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1055\/s-0038-1657637","volume":"78","author":"PA Borne von dem","year":"1997","unstructured":"Borne von dem, P. A., Mosnier, L. O., Tans, G., Meijers, J. C. & Bouma, B. N. Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine. Thromb. Haemost. 78, 834\u2013839 (1997).","journal-title":"Thromb. Haemost."},{"key":"64155_CR22","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","volume":"86","author":"PA Borne von dem","year":"1995","unstructured":"Borne von dem, P. A., Meijers, J. C. & Bouma, B. N. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86, 3035\u20133042 (1995).","journal-title":"Blood"},{"key":"64155_CR23","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1073\/pnas.73.8.2554","volume":"73","author":"JH Griffin","year":"1976","unstructured":"Griffin, J. H. & Cochrane, C. G. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc. Natl Acad. Sci. USA 73, 2554\u20132558 (1976).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64155_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7326\/0003-4819-73-4-545","volume":"73","author":"JW Mason","year":"1970","unstructured":"Mason, J. W., Kleeberg, U., Dolan, P. & Colman, R. W. Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann. Intern. Med. 73, 545\u2013551 (1970).","journal-title":"Ann. Intern. Med."},{"key":"64155_CR25","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1128\/AAC.02066-12","volume":"57","author":"L Heinbockel","year":"2013","unstructured":"Heinbockel, L. et al. Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors. Antimicrob. Agents Chemother. 57, 1480\u20131487 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64155_CR26","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1038\/emm.2017.75","volume":"49","author":"S B\u00e1rcena-Varela","year":"2017","unstructured":"B\u00e1rcena-Varela, S. et al. Coupling killing to neutralization: combined therapy with ceftriaxone\/Pep19-2.5 counteracts sepsis in rabbits. Exp. Mol. Med. 49, e345\u2013e345 (2017).","journal-title":"Exp. Mol. Med."},{"key":"64155_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1182\/blood.V49.6.947.947","volume":"49","author":"J Niemetz","year":"1977","unstructured":"Niemetz, J. & Morrison, D. C. Lipid A as the biologically active moiety in bacterial endotoxin (LPS)- initiated generation of procoagulant activity by peripheral blood leukocytes. Blood 49, 947\u2013956 (1977).","journal-title":"Blood"},{"key":"64155_CR28","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1128\/MCB.9.6.2752","volume":"9","author":"SA Gregory","year":"1989","unstructured":"Gregory, S. A., Morrissey, J. H. & Edgington, T. S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol. Cell. Biol. 9, 2752\u20132755 (1989).","journal-title":"Mol. Cell. Biol."},{"key":"64155_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862\u2013874 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"64155_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1684\/ecn.2011.0281","volume":"22","author":"E Tamayo","year":"2011","unstructured":"Tamayo, E. et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw 22, 82\u201387 (2011).","journal-title":"Eur. Cytokine Netw"},{"key":"64155_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/315214","volume":"181","author":"CA Gogos","year":"2000","unstructured":"Gogos, C. A., Drosou, E., Bassaris, H. P. & Skoutelis, A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 181, 176\u2013180 (2000).","journal-title":"J. Infect. Dis."},{"key":"64155_CR32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1128\/IAI.01213-09","volume":"78","author":"JT Muenzer","year":"2010","unstructured":"Muenzer, J. T. et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78, 1582\u20131592 (2010).","journal-title":"Infect. Immun."},{"key":"64155_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/cyto.990110402","volume":"11","author":"MR Loken","year":"1990","unstructured":"Loken, M. R., Brosnan, J. M., Bach, B. A. & Ault, K. A. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11, 453\u2013459 (1990).","journal-title":"Cytometry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64155-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:47:33Z","timestamp":1670320053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64155-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64155"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64155-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7142"}}